A detailed history of Baystate Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Baystate Wealth Management LLC holds 1,898 shares of LLY stock, worth $1.51 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,898
Previous 953 99.16%
Holding current value
$1.51 Million
Previous $511,000 116.44%
% of portfolio
0.08%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $496,304 - $585,077
945 Added 99.16%
1,898 $1.11 Million
Q3 2023

Oct 25, 2023

BUY
$434.7 - $599.3 $85,635 - $118,062
197 Added 26.06%
953 $511,000
Q2 2023

Sep 21, 2023

SELL
$350.74 - $468.98 $1.05 Million - $1.4 Million
-2,980 Reduced 79.76%
756 $354,000
Q2 2023

Aug 02, 2023

BUY
$350.74 - $468.98 $1.14 Million - $1.53 Million
3,262 Added 688.19%
3,736 $1.75 Million
Q1 2023

Apr 25, 2023

BUY
$310.63 - $364.82 $2,485 - $2,918
8 Added 1.72%
474 $162,000
Q4 2022

Jan 12, 2023

BUY
$321.55 - $374.67 $321 - $374
1 Added 0.22%
466 $171,000
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $592 - $675
2 Added 0.43%
465 $150,000
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $278 - $327
1 Added 0.22%
463 $150,000
Q1 2022

Apr 19, 2022

BUY
$234.69 - $291.66 $469 - $583
2 Added 0.43%
462 $132,000
Q4 2021

Jan 21, 2022

SELL
$224.85 - $279.04 $1,124 - $1,395
-5 Reduced 1.08%
460 $127,000
Q3 2021

Nov 05, 2021

BUY
$221.6 - $272.71 $1,772 - $2,181
8 Added 1.75%
465 $108,000
Q2 2021

Jul 26, 2021

BUY
$180.55 - $233.54 $7,041 - $9,108
39 Added 9.33%
457 $105,000
Q1 2021

Apr 21, 2021

BUY
$164.32 - $212.72 $328 - $425
2 Added 0.48%
418 $78,000
Q4 2020

Jan 15, 2021

BUY
$130.46 - $172.63 $130 - $172
1 Added 0.24%
416 $70,000
Q3 2020

Oct 14, 2020

BUY
$146.22 - $169.13 $438 - $507
3 Added 0.73%
415 $61,000
Q2 2020

Jul 28, 2020

BUY
$136.42 - $164.18 $34,105 - $41,045
250 Added 154.32%
412 $68,000
Q1 2020

Apr 22, 2020

BUY
$119.05 - $147.35 $119 - $147
1 Added 0.62%
162 $22,000
Q4 2019

Jan 21, 2020

BUY
$106.92 - $132.43 $5,025 - $6,224
47 Added 41.23%
161 $21,000
Q3 2019

Oct 30, 2019

BUY
$106.79 - $116.16 $6,941 - $7,550
65 Added 132.65%
114 $13,000
Q2 2019

Jul 02, 2019

SELL
$110.79 - $129.32 $6,315 - $7,371
-57 Reduced 53.77%
49 $6,000
Q1 2019

Apr 25, 2019

BUY
$111.31 - $131.02 $3,561 - $4,192
32 Added 43.24%
106 $13,000
Q4 2018

Jan 24, 2019

SELL
$105.9 - $118.64 $2,859 - $3,203
-27 Reduced 26.73%
74 $9,000
Q2 2018

Jul 17, 2018

SELL
$75.7 - $86.88 $5,677 - $6,516
-75 Reduced 42.61%
101 $9,000
Q1 2018

Apr 24, 2018

SELL
$74.21 - $87.6 $103,448 - $122,114
-1,394 Reduced 88.79%
176 $14,000
Q4 2017

Jan 23, 2018

SELL
$81.94 - $87.89 $5,653 - $6,064
-69 Reduced 4.21%
1,570 $134,000
Q3 2017

Oct 10, 2017

BUY
$77.07 - $85.54 $126,317 - $140,200
1,639
1,639 $143,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Baystate Wealth Management LLC Portfolio

Follow Baystate Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.